Kent Lake Capital’s CareDx CDNA Stock Holding History

Kent Lake Capital’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-618,301	Closed	-$7.42M	–	47
2023 Q4	$7.42M	Sell	618,301 -757,157	-55%	-$6.2M	2.87%	15
2023 Q3	$9.63M	Buy	+1,375,458	New	+$12.7M	3.7%	11

Other funds holding CDNA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Kent Lake Capital's CDNA Position: Q1 2024 in Review

Kent Lake Capital sold out of CareDx (CDNA) in Q1 2024, closing a stake of 618,301 shares — an estimated $7.42M sold.

Kent Lake Capital first reported a position in CDNA in Q3 2023 and held it in 2 quarters. The position peaked at $9.63M in Q3 2023. 147 funds tracked by Wall St. Rank hold CDNA as of Q1 2024.

Kent Lake Capital reported no remaining CareDx position as of Q1 2024 after selling out during the quarter.
Kent Lake Capital sold 618,301 CareDx shares in Q1 2024, an estimated $7.42M.
Kent Lake Capital first reported a position in CareDx in Q3 2023 and held it in 2 quarters.
Kent Lake Capital's CareDx position peaked at $9.63M in Q3 2023.
147 funds tracked by Wall St. Rank held CareDx as of Q1 2024.

Based on Kent Lake Capital's 13F filing for Q1 2024, filed 15 May 2024.